Retatrutide is a once-weekly injection that mimics three hormones involved in appetite, blood sugar, and how the body uses energy: GLP-1: lowers appetite and blood sugar GIP: lowers appetite and blood sugar Glucagon: increases energy expenditure and the breakdown of stored fat, including fat in the liver The glucagon component is what separates retatrutide from semaglutide, which mimics one hormone (GLP-1), and tirzepatide, which mimics two (GLP-1 and GIP)
At its core, this product contains 500 mcg of BPC-157 per capsule, designed to support injury recovery, gastrointestinal health, and collagen synthesis
The dual burden of obesity and type-2 diabetes is rapidly emerging as a major public health challenge in India
If you experience severe or persistent abdominal pain, seek medical attention immediately, as it could indicate a more serious condition like pancreatitis
Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells
This kinase activity is vital for most of insulins metabolic actions
